Evidence map›Paper›PMID 35013428›Full record

ArticleScientific reports2022

Accuracy of mutational signature software on correlated signatures.

Yang Wu, Ellora Hui Zhen Chua, Alvin Wei Tian Ng, Arnoud Boot, Steven G Rozen

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yang WuProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, 169857, Singapore.
Ellora Hui Zhen ChuaDepartment of Biological Sciences, National University of Singapore, Singapore, 117558, Singapore.
Alvin Wei Tian NgProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, 169857, Singapore.
Arnoud BootProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, 169857, Singapore.
Steven G RozenProgramme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, 169857, Singapore. steverozen@gmail.com.

Funding

Singapore National Medical Research Council NMRC/CIRG/1422/2015
6 · The paper itself

Abstract

Mutational signatures are characteristic patterns of mutations generated by exogenous mutagens or by endogenous mutational processes. Mutational signatures are important for research into DNA damage and repair, aging, cancer biology, genetic toxicology, and epidemiology. Unsupervised learning can infer mutational signatures from the somatic mutations in large numbers of tumors, and separating correlated signatures is a notable challenge for this task. To investigate which methods can best meet this challenge, we assessed 18 computational methods for inferring mutational signatures on 20 synthetic data sets that incorporated varying degrees of correlated activity of two common mutational signatures. Performance varied widely, and four methods noticeably outperformed the others: hdp (based on hierarchical Dirichlet processes), SigProExtractor (based on multiple non-negative matrix factorizations over resampled data), TCSM (based on an approach used in document topic analysis), and mutSpec.NMF (also based on non-negative matrix factorization). The results underscored the complexities of mutational signature extraction, including the importance and difficulty of determining the correct number of signatures and the importance of hyperparameters. Our findings indicate directions for improvement of the software and show a need for care when interpreting results from any of these methods, including the need for assessing sensitivity of the results to input parameters.

Indexed as

AlgorithmsDNA Mutational AnalysisMutationSoftwareBiomarkers, TumorHigh-Throughput Nucleotide SequencingHumansNeoplasmsPattern Recognition, AutomatedReproducibility of ResultsBiomarkers, Tumor

Identifiers

PMID35013428
PMCPMC8748538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.